Tadalafil (INN) is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED).
The global Tadalafil Oral market is projected to grow from US$ 131 million in 2024 to US$ 162 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period.
Tadalafil oral is a medication used to treat erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). It is marketed under various brand names, including Cialis. Tadalafil belongs to a class of drugs called phosphodiesterase type 5 inhibitors (PDE5 inhibitors), which work by increasing blood flow to the penis, helping men achieve and maintain an erection. Market trends for tadalafil can vary over time and across regions. Factors such as the introduction of generic versions, changes in pricing, competition from other ED medications, and consumer preferences can influence market dynamics. According to recent 91制片厂 reports, the global tadalafil oral market is expected to grow due to increasing cases of erectile dysfunction and benign prostatic hyperplasia among the aging population, as well as growing awareness and healthcare expenditure for these conditions. Additionally, the availability of various formulation types and convenience in purchasing medication online are expected to drive market growth.
Report Covers:
This report presents an overview of global market for Tadalafil Oral, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Tadalafil Oral, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Tadalafil Oral, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tadalafil Oral sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Tadalafil Oral market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Tadalafil Oral sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Aurobindo
Sun Pharma
Alembic Pharmaceuticals
Mylan
Cipla
Ajanta Pharma Ltd.
Dr. Reddys Laboratories
Qilu Pharmaceutical
Segment by Type
2.5 mg tablets
5 mg tablets
10mg tablets
20 mg tablets
Segment by Application
Hospital
Drug store
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Tadalafil Oral in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Tadalafil Oral manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tadalafil Oral sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Tadalafil Oral Product Introduction
1.2 Market by Type
1.2.1 Global Tadalafil Oral Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 2.5 mg tablets
1.2.3 5 mg tablets
1.2.4 10mg tablets
1.2.5 20 mg tablets
1.3 Market by Application
1.3.1 Global Tadalafil Oral Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tadalafil Oral Sales Estimates and Forecasts 2019-2030
2.2 Global Tadalafil Oral Revenue by Region
2.2.1 Global Tadalafil Oral Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Tadalafil Oral Revenue by Region (2019-2024)
2.2.3 Global Tadalafil Oral Revenue by Region (2025-2030)
2.2.4 Global Tadalafil Oral Revenue Market Share by Region (2019-2030)
2.3 Global Tadalafil Oral Sales Estimates and Forecasts 2019-2030
2.4 Global Tadalafil Oral Sales by Region
2.4.1 Global Tadalafil Oral Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Tadalafil Oral Sales by Region (2019-2024)
2.4.3 Global Tadalafil Oral Sales by Region (2025-2030)
2.4.4 Global Tadalafil Oral Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Tadalafil Oral Sales by Manufacturers
3.1.1 Global Tadalafil Oral Sales by Manufacturers (2019-2024)
3.1.2 Global Tadalafil Oral Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tadalafil Oral in 2023
3.2 Global Tadalafil Oral Revenue by Manufacturers
3.2.1 Global Tadalafil Oral Revenue by Manufacturers (2019-2024)
3.2.2 Global Tadalafil Oral Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Tadalafil Oral Revenue in 2023
3.3 Global Key Players of Tadalafil Oral, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Tadalafil Oral Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Tadalafil Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Tadalafil Oral, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Tadalafil Oral, Product Offered and Application
3.8 Global Key Manufacturers of Tadalafil Oral, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tadalafil Oral Sales by Type
4.1.1 Global Tadalafil Oral Historical Sales by Type (2019-2024)
4.1.2 Global Tadalafil Oral Forecasted Sales by Type (2025-2030)
4.1.3 Global Tadalafil Oral Sales Market Share by Type (2019-2030)
4.2 Global Tadalafil Oral Revenue by Type
4.2.1 Global Tadalafil Oral Historical Revenue by Type (2019-2024)
4.2.2 Global Tadalafil Oral Forecasted Revenue by Type (2025-2030)
4.2.3 Global Tadalafil Oral Revenue Market Share by Type (2019-2030)
4.3 Global Tadalafil Oral Price by Type
4.3.1 Global Tadalafil Oral Price by Type (2019-2024)
4.3.2 Global Tadalafil Oral Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Tadalafil Oral Sales by Application
5.1.1 Global Tadalafil Oral Historical Sales by Application (2019-2024)
5.1.2 Global Tadalafil Oral Forecasted Sales by Application (2025-2030)
5.1.3 Global Tadalafil Oral Sales Market Share by Application (2019-2030)
5.2 Global Tadalafil Oral Revenue by Application
5.2.1 Global Tadalafil Oral Historical Revenue by Application (2019-2024)
5.2.2 Global Tadalafil Oral Forecasted Revenue by Application (2025-2030)
5.2.3 Global Tadalafil Oral Revenue Market Share by Application (2019-2030)
5.3 Global Tadalafil Oral Price by Application
5.3.1 Global Tadalafil Oral Price by Application (2019-2024)
5.3.2 Global Tadalafil Oral Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Tadalafil Oral Market Size by Type
6.1.1 US & Canada Tadalafil Oral Sales by Type (2019-2030)
6.1.2 US & Canada Tadalafil Oral Revenue by Type (2019-2030)
6.2 US & Canada Tadalafil Oral Market Size by Application
6.2.1 US & Canada Tadalafil Oral Sales by Application (2019-2030)
6.2.2 US & Canada Tadalafil Oral Revenue by Application (2019-2030)
6.3 US & Canada Tadalafil Oral Market Size by Country
6.3.1 US & Canada Tadalafil Oral Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Tadalafil Oral Sales by Country (2019-2030)
6.3.3 US & Canada Tadalafil Oral Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Tadalafil Oral Market Size by Type
7.1.1 Europe Tadalafil Oral Sales by Type (2019-2030)
7.1.2 Europe Tadalafil Oral Revenue by Type (2019-2030)
7.2 Europe Tadalafil Oral Market Size by Application
7.2.1 Europe Tadalafil Oral Sales by Application (2019-2030)
7.2.2 Europe Tadalafil Oral Revenue by Application (2019-2030)
7.3 Europe Tadalafil Oral Market Size by Country
7.3.1 Europe Tadalafil Oral Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Tadalafil Oral Sales by Country (2019-2030)
7.3.3 Europe Tadalafil Oral Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Tadalafil Oral Market Size
8.1.1 China Tadalafil Oral Sales (2019-2030)
8.1.2 China Tadalafil Oral Revenue (2019-2030)
8.2 China Tadalafil Oral Market Size by Application
8.2.1 China Tadalafil Oral Sales by Application (2019-2030)
8.2.2 China Tadalafil Oral Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Tadalafil Oral Market Size by Type
9.1.1 Asia Tadalafil Oral Sales by Type (2019-2030)
9.1.2 Asia Tadalafil Oral Revenue by Type (2019-2030)
9.2 Asia Tadalafil Oral Market Size by Application
9.2.1 Asia Tadalafil Oral Sales by Application (2019-2030)
9.2.2 Asia Tadalafil Oral Revenue by Application (2019-2030)
9.3 Asia Tadalafil Oral Sales by Region
9.3.1 Asia Tadalafil Oral Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Tadalafil Oral Revenue by Region (2019-2030)
9.3.3 Asia Tadalafil Oral Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Tadalafil Oral Market Size by Type
10.1.1 Middle East, Africa and Latin America Tadalafil Oral Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Tadalafil Oral Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Tadalafil Oral Market Size by Application
10.2.1 Middle East, Africa and Latin America Tadalafil Oral Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Tadalafil Oral Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Tadalafil Oral Sales by Country
10.3.1 Middle East, Africa and Latin America Tadalafil Oral Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Tadalafil Oral Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Tadalafil Oral Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Tadalafil Oral Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Eli Lilly Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Tadalafil Oral Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Teva Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Aurobindo
11.3.1 Aurobindo Company Information
11.3.2 Aurobindo Overview
11.3.3 Aurobindo Tadalafil Oral Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Aurobindo Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Aurobindo Recent Developments
11.4 Sun Pharma
11.4.1 Sun Pharma Company Information
11.4.2 Sun Pharma Overview
11.4.3 Sun Pharma Tadalafil Oral Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Sun Pharma Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharma Recent Developments
11.5 Alembic Pharmaceuticals
11.5.1 Alembic Pharmaceuticals Company Information
11.5.2 Alembic Pharmaceuticals Overview
11.5.3 Alembic Pharmaceuticals Tadalafil Oral Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Alembic Pharmaceuticals Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Alembic Pharmaceuticals Recent Developments
11.6 Mylan
11.6.1 Mylan Company Information
11.6.2 Mylan Overview
11.6.3 Mylan Tadalafil Oral Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Mylan Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan Recent Developments
11.7 Cipla
11.7.1 Cipla Company Information
11.7.2 Cipla Overview
11.7.3 Cipla Tadalafil Oral Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Cipla Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cipla Recent Developments
11.8 Ajanta Pharma Ltd.
11.8.1 Ajanta Pharma Ltd. Company Information
11.8.2 Ajanta Pharma Ltd. Overview
11.8.3 Ajanta Pharma Ltd. Tadalafil Oral Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Ajanta Pharma Ltd. Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ajanta Pharma Ltd. Recent Developments
11.9 Dr. Reddys Laboratories
11.9.1 Dr. Reddys Laboratories Company Information
11.9.2 Dr. Reddys Laboratories Overview
11.9.3 Dr. Reddys Laboratories Tadalafil Oral Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Dr. Reddys Laboratories Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dr. Reddys Laboratories Recent Developments
11.10 Qilu Pharmaceutical
11.10.1 Qilu Pharmaceutical Company Information
11.10.2 Qilu Pharmaceutical Overview
11.10.3 Qilu Pharmaceutical Tadalafil Oral Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Qilu Pharmaceutical Tadalafil Oral Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Qilu Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tadalafil Oral Industry Chain Analysis
12.2 Tadalafil Oral Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tadalafil Oral Production Mode & Process
12.4 Tadalafil Oral Sales and Marketing
12.4.1 Tadalafil Oral Sales Channels
12.4.2 Tadalafil Oral Distributors
12.5 Tadalafil Oral Customers
13 Market Dynamics
13.1 Tadalafil Oral Industry Trends
13.2 Tadalafil Oral Market Drivers
13.3 Tadalafil Oral Market Challenges
13.4 Tadalafil Oral Market Restraints
14 Key Findings in The Global Tadalafil Oral Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Eli Lilly
Teva
Aurobindo
Sun Pharma
Alembic Pharmaceuticals
Mylan
Cipla
Ajanta Pharma Ltd.
Dr. Reddys Laboratories
Qilu Pharmaceutical
听
听
*If Applicable.